Exclusion Criteria:~* The subject is currently taking or has taken a medication for the treatment of
Alzheimer's disease or dementia within 60 days prior to Screening Visit 1, or is participating in cognitive
therapy for the treatment of Alzheimer's disease or dementia.~* The subject has clinically significant abnormal
laboratory values at Screening Visit 1 as determined by the investigator.~* The subject has a history of any
significant neurologic disease other than Alzheimer's disease including Parkinson's disease, multi-infarct or
vascular dementia, Huntington's disease, normal pressure hydrocephalus, progressive supranuclear palsy,
multiple sclerosis, any seizures, mental retardation or a history of significant head trauma followed by
persistent neurologic deficits or known structural brain abnormalities.~* In the opinion of the investigator,
the subject has any clinically significant uncontrolled medical or psychiatric illness.~* The subject has a
known hypersensitivity or intolerance to donepezil that lead to discontinuation or a known reported history of
donepezil treatment failure.
